For decades, neurological research has focused on proteins and lipids as the architects of myelin structure, but a growing body of evidence points to glycans — sugar chains attached to proteins — as equally critical regulators. This finding matters because disruptions to saltatory conduction underlie conditions ranging from multiple sclerosis to peripheral neuropathies, and identifying new molecular levers could open unexpected therapeutic avenues.
The work centers on MGAT5B, a glycosyltransferase expressed specifically in the brain, which adds a β1,6-GlcNAc branch to O-mannose glycans. Mice lacking the Mgat5b gene developed structurally widened nodes of Ranvier in brain white matter — the tiny gaps between myelin segments where action potentials are regenerated. Electrophysiological recordings confirmed real functional consequences: measurable delays and increased variability in axonal conduction velocity. Glycoproteomic profiling identified neurofascin 186 (NF186) — a cornerstone scaffolding glycoprotein at the node — as a direct substrate of MGAT5B. Critically, when those O-mannose branches were absent, the interaction between NF186 and Contactin 1 was upregulated, suggesting that glycan branching normally dampens this protein-protein interaction to maintain node geometry. Neuron-specific genetic rescue of MGAT5B expression reversed both structural and electrophysiological deficits, confirming the effect is cell-autonomous within neurons.
This study introduces a glycan-level regulatory layer into node-of-Ranvier biology that was not previously appreciated. The finding that a single glycosyltransferase shapes conduction velocity by modulating protein interactions at a nanoscale node structure is conceptually significant. However, all experiments are in mice, and the relevance to human demyelinating or conduction disorders remains speculative. MGAT5B expression varies across brain regions and developmental stages, so the full scope of these effects awaits mapping. Whether pharmacologically modulating O-mannose branching is tractable remains an open and distant question. Overall, this is an incremental but mechanistically precise advance in glycobiology's contribution to neuroscience.